Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples